| Literature DB >> 28468971 |
Matthew R Olson1, Benjamin J Ulrich2, Sarah A Hummel2, Ibrahim Khan2, Brice Meuris2, Yesesri Cherukuri3, Alexander L Dent4, Sarath Chandra Janga3, Mark H Kaplan1,4.
Abstract
IL-2 is a pleiotropic cytokine that promotes the differentiation of Th cell subsets, including Th1, Th2, and Th9 cells, but it impairs the development of Th17 and T follicular helper cells. Although IL-2 is produced by all polarized Th subsets to some level, how it impacts cytokine production when effector T cells are restimulated is unknown. We show in this article that Golgi transport inhibitors (GTIs) blocked IL-9 production. Mechanistically, GTIs blocked secretion of IL-2 that normally feeds back in a paracrine manner to promote STAT5 activation and IL-9 production. IL-2 feedback had no effect on Th1- or Th17-signature cytokine production, but it promoted Th2- and Th9-associated cytokine expression. These data suggest that the use of GTIs results in an underestimation of the presence of type 2 cytokine-secreting cells and highlight IL-2 as a critical component in optimal cytokine production by Th2 and Th9 cells in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28468971 PMCID: PMC5470780 DOI: 10.4049/jimmunol.1601792
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422